The Effects of Organic Chromium Supplementation on Clinical Parameters of the Metabolic Syndrome, in Patients With Type 2 Diabetes Mellitus. A Randomised, Double-Blind, Placebo-Controlled Trial

NCT00145093 Phase 3 COMPLETED

The purpose of this study is to determine whether chromium (yeast), is effective in improving glycaemic control and insulin resistance.

Details

Lead sponsor	Medical Research Foundation, The Netherlands
Phase	Phase 3
Status	COMPLETED
Enrolment	60
Start date	2004-08
Completion	2005-02

Conditions

• Diabetes Mellitus, Type 2

Interventions

• Baker's yeast (Bio Chromium)

Primary outcomes

• To determine the effect of Baker's yeast treatment on glycemicic control and insulin resistance when given in combination with oral blood glucose lowering therapy to patients with type 2 diabetes mellitus

Countries

Netherlands